Get started
Author

Rosaria Remelli

ORCID: 0000-0002-7910-873X
Observed ORCID: 0000-0002-7910-873X
OpenAlex ID: A5021235936
Chlorophyll Binding to Monomeric Light-harvesting Complex
1999 · Rosaria Remelli, Claudio Varotto, et al. · Journal of Biological Chemistry · 223
PDF
The neoxanthin binding site of the major light harvesting complex (LHCII) from higher plants
1999 · Roberta Croce, Rosaria Remelli, et al. · FEBS Letters · 125
Evidence that the metabotropic glutamate receptor 5 antagonist MPEP may act as an inhibitor of the norepinephrine transporter in vitro and in vivo
2003 · Christian A. Heidbreder, Massimiliano Bianchi, et al. · Synapse · 74
Actin-binding Protein α-Actinin-1 Interacts with the Metabotropic Glutamate Receptor Type 5b and Modulates the Cell Surface Expression and Function of the Receptor
2007 · Nuria Cabello, Rosaria Remelli, et al. · Journal of Biological Chemistry · 41
PDF
Functional Characterization of a Small-Molecule Inhibitor of the DKK1-LRP6 Interaction
2012 · Sara Iozzi, Rosaria Remelli, et al. · ISRN Molecular Biology · 34
PDF
The C‐terminus of the metabotropic glutamate receptor 1b regulates dimerization of the receptor
2007 · Rosaria Remelli, Melanie J. Robbins, et al. · Journal of Neurochemistry · 22
Recombinant Adeno Associated Viral (AAV) vector type 9 delivery of Ex1-Q138-mutant huntingtin in the rat striatum as a short-time model for in vivo studies in drug discovery
2015 · Ilaria Ceccarelli, Pasquale Fiengo, et al. · Neurobiology of Disease · 14
Discovery of a Potent, Selective, and Orally Bioavailable Tool Compound for Probing the Role of Lysophosphatidic Acid Type 2 Receptor Antagonists in Fibrotic Disorders
2023 · Elisabetta Armani, Andrea Rizzi, et al. · Journal of Medicinal Chemistry · 10
Discovery of novel phenoxazinone derivatives as DKK1/LRP6 interaction inhibitors: Synthesis, biological evaluation and structure–activity relationships
2016 · Savvas Thysiadis, Spyros Mpousis, et al. · Bioorganic & Medicinal Chemistry · 8
Novel Cyclohexyl Amido Acid Antagonists of Lysophosphatidic Acid Type 1 Receptor for the Treatment of Pulmonary Fibrosis
2025 · Marta Giuliani, Andrea Rizzi, et al. · ACS Medicinal Chemistry Letters · 4
Design, Synthesis, and Activity of a Novel Series of Pyridazine-Based ALK5 Inhibitors
2024 · Daniele Pala, Paolo Ronchi, et al. · ACS Medicinal Chemistry Letters · 4
PDF
Development and validation of a multi-readout drug screening platform, modelling in vitro asthmatic feature of goblet cells hyperplasia, based on 3D cultures of human primary lung epithelial cells at the Air-Liquide Interface (ALI)
2026 · Nicola Pianca, Marianna Sasso, et al. · European Respiratory Journal
Integrated in vitro and in vivo IL13–driven goblet cell hyperplasia models for translational evaluation of airway remodeling therapies
2026 · Matthew Pedercini, Nicola Pianca, et al. · European Respiratory Journal
Discovery of a Novel Lung-Restricted ALK5 Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis
2026 · Paolo Ronchi, Daniela Pizzirani, et al. · Journal of Medicinal Chemistry
RNA Extraction Alternative Method for SARS-CoV-2 Molecular Diagnosis
2021 · Elisa Bianchini, Francesco Rossignolo, et al. · Preprints.org
Dkk1/lrp6相互作用の阻害剤としての新規フェノキサジノン誘導体の発見:合成と生物学的評価と構造活性相関
2016 · Savvas Thysiadis, Spyros Mpousis, et al. · Bioorganic & Medicinal Chemistry
Viral vector delivery of mutant huntingtin as model of huntington's disease in the rat: in vivo and in vitro study
2011 · Carla Scali, Ilaria Ceccarelli, et al. · CINECA IRIS Institutial research information system (University of Pisa)
Recombinant Adeno Associated Viral (AAV) vector delivery of mutant huntingtin as rat model for in vitro and in vivo studies.
2011 · Carla Scali, Ilaria Ceccarelli, et al. · CINECA IRIS Institutial research information system (University of Pisa)
Works count: 18
Citation count: 559
H-index: 8
I10-index: 8
Year
Topic
Type